Nicotinamide adenine dinucleotide (NAD+) is both a redox cofactor and a signaling substrate that couples energy state to stress response, chromatin state, DNA repair, neuroinflammation, and proteostasis.verdin2015 2015, verdin2015lautrup2019 2019, lautrup2019 In the aging brain, NAD+ pools decline across neurons, glia, and vascular cells, producing a systems-level vulnerability pattern that overlaps with Alzheimer disease (AD), Parkinson disease (PD), and 4R-tau disorders such as corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP).lautrup2019 2019, lautrup2019hou2021 2021, hou2021
Unlike purely metabolic pathways, NAD+ signaling is substrate-limited: once NAD+ falls below a functional threshold, competing enzymes (notably Sirtuin signaling, PARP-mediated DNA damage response, and CD38/CD157 ectoenzymes) begin to trade off against each other. The consequence is a feed-forward cycle of mitochondrial inefficiency, impaired DNA maintenance, inflammatory amplification, and reduced neuronal resilience.verdin2015 2015, verdin2015cant2015 2015, cant2015
Sirtuins are NAD+-dependent deacylases that function as energy-sensitive transcriptional and metabolic rheostats. In the CNS:
When NAD+ availability declines, sirtuin flux drops. This shifts the brain toward hyperacetylated stress phenotypes, reduced mitochondrial reserve, weaker proteostasis, and higher inflammatory tone.lautrup2019 2019, lautrup2019pillai2015 2015, pillai2015
Poly(ADP-ribose) polymerases (especially PARP1) consume NAD+ to support DNA repair. In chronic oxidative stress states, PARP activity can become maladaptively high, effectively siphoning NAD+ away from sirtuins and mitochondrial maintenance.berger2021 2021, berger2021fang2019 2019, fang2019 This creates a substrate competition problem:
This loop is one mechanistic bridge between oxidative injury and progressive neuronal dysfunction.berger2021 2021, berger2021madan2023 2023, madan2023
CD38 and CD157 metabolize NAD+ into signaling metabolites (including cADPR) that reshape calcium dynamics and immune-cell activation states.chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARP In aging and neuroinflammatory conditions, CD38 upregulation is associated with accelerated NAD+ depletion and glial activation.chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARPcamachopereira2016 2016, camachopereira2016 From a pathway perspective, CD38 behaves as both a marker and a driver of the inflammatory-metabolic transition.
The brain relies heavily on salvage synthesis to maintain NAD+:
Age-related or stress-induced impairment at these nodes reduces recovery capacity after NAD+ consumption events.yoshino2018 2018, NAD+ intermediates: the biology and therapeutic potential of NMN and NRrevollo2004 2004, revollo2004
NAD+ signaling is compartment-dependent rather than uniform. Cytosolic, nuclear, and mitochondrial pools are functionally coupled but kinetically distinct, so a systemic rise in blood NAD+ does not guarantee adequate restoration inside vulnerable neuronal compartments.lautrup2019 2019, lautrup2019cant2015 2015, cant2015yoshino2018 2018, NAD+ intermediates: the biology and therapeutic potential of NMN and NR
The nucleus is a high-demand NAD+ sink during genotoxic stress because PARPs and sirtuins co-compete for substrate. Under chronic DNA damage pressure, PARP-dominant states can reduce nuclear NAD+ availability for SIRT1/SIRT6-dependent transcriptional adaptation and chromatin repair.kugel2014 2014, Chromatin and beyond: the multitasking roles for SIRT6berger2021 2021, berger2021chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARP
Mitochondrial NAD+ supports oxidative phosphorylation and SIRT3-dependent deacetylation programs that preserve electron transport chain function, antioxidant buffering, and mitophagy competence.pillai2015 2015, pillai2015fang2019 2019, fang2019madan2023 2023, madan2023 In neurons with long axonal arbors and high pacemaker load, small deficits in mitochondrial NAD+ handling can produce large downstream energy penalties.
Cytosolic NAD+ dynamics influence glycolytic reserve and calcium-linked stress signaling, while membrane-proximal CD38 activity can locally accelerate extracellular and pericellular NAD+ turnover in inflammatory contexts.chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARPcamachopereira2016 2016, camachopereira2016 This contributes to glia-neuron coupling failure in chronic neuroinflammatory states.
Total NAD+ abundance and NAD+/NADH ratio are related but not equivalent. The ratio informs metabolic directionality, mitochondrial electron pressure, and stress-pathway activation thresholds.verdin2015 2015, verdin2015cant2015 2015, cant2015
In practical terms:
AD combines amyloid stress, tau pathology, synaptic failure, and glial dysregulation. NAD+ signaling intersects each domain:
These mechanisms support NAD+ restoration as a network stabilizer rather than a single-target intervention.lautrup2019 2019, lautrup2019hou2021 2021, hou2021
Dopaminergic neurons in Substantia nigra pars compacta have high oxidative load and strict mitochondrial requirements. In PD models, NAD+ repletion improves mitochondrial bioenergetics and supports mitophagy-linked quality control.schndorf2018 2018, schndorf2018brakedal2022 2022, brakedal2022
NAD+ signaling also interfaces with alpha-synuclein stress: metabolic fragility and proteostatic strain co-amplify each other, making substrate restoration potentially useful in combination with proteostasis-targeting strategies.lautrup2019 2019, lautrup2019lautrup2019a 2019, NAD+ in brain aging and neurodegenerative disorders: from mechanisms to thera...
CBS and PSP are dominated by tau-driven network degeneration with pronounced glial and brainstem involvement. NAD+ biology is relevant through several channels:
Current human evidence is still indirect (mostly extrapolated from AD/PD aging studies), but mechanistic plausibility for tauopathy is high enough to justify controlled trials and biomarker-first protocols.lautrup2019 2019, lautrup2019hou2021 2021, hou2021
NAD+ signaling should be viewed as a coupling layer between Mitochondrial dysfunction pathway, Autophagy-lysosomal pathway, and Neuroinflammation pathway.
Key coupling effects:
This explains why NAD+ interventions often show strongest effects in multidomain regimens rather than monotherapy trials.lautrup2019 2019, lautrup2019cant2015 2015, cant2015aman2018 2018, aman2018
NAD+ stress is not distributed uniformly across CNS cell classes.
Large projection neurons (corticospinal, nigrostriatal, and frontostriatal systems) carry high ATP demand and long-distance transport burdens, making them sensitive to NAD+-dependent mitochondrial inefficiency and transport failure.lautrup2019 2019, lautrup2019schndorf2018 2018, schndorf2018brakedal2022 2022, brakedal2022
Activated glia can become major determinants of local NAD+ turnover through inflammatory CD38 induction and cytokine-driven metabolic rewiring. This can produce local substrate depletion and sustain inflammatory feed-forward loops that damage neighboring neurons.chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARPcamachopereira2016 2016, camachopereira2016
Myelin maintenance and axonal metabolic support are energy-intensive. While human evidence remains less mature than in neuronal models, NAD+ pressure likely contributes to white-matter vulnerability where mitochondrial reserve is already marginal.lautrup2019 2019, lautrup2019hou2021 2021, hou2021
NAD+ precursor classes:
Across clinical studies, these agents consistently raise peripheral NAD+ metrics; translation to robust clinical endpoints remains mixed and likely depends on disease stage, target engagement, and co-interventions.yoshino2018 2018, NAD+ intermediates: the biology and therapeutic potential of NMN and NRmartens2018 2018, martens2018
Potentially complementary strategies:
For translational programs, dose selection should target demonstrable NAD+ engagement rather than fixed nutraceutical conventions. A useful sequence:
Safety and interpretive guardrails:
Future CNS trials should prioritize:
A multi-layer biomarker stack can separate pharmacologic failure from biological non-responsiveness:
This layered approach supports adaptive trial decisions and can reduce false-negative interpretation in heterogeneous cohorts.lautrup2019 2019, lautrup2019madan2023 2023, madan2023martens2018 2018, martens2018
Important unresolved points:
Therefore, the current evidence supports NAD+ signaling as a strong mechanistic target with moderate clinical certainty, not yet a stand-alone disease-modifying standard.hou2021 2021, hou2021martens2018 2018, martens2018
A practical translational framework for CBS/PSP studies:
This approach can reduce false negatives caused by underdosing or biologically unengaged cohorts.
| Dimension | Current confidence | Rationale |
|---|---|---|
| Mechanistic coherence | Moderate-High | Strong convergence of sirtuin/PARP/CD38 competition and mitochondrial coupling |
| Preclinical reproducibility | Moderate | Multiple models show directionally consistent metabolic rescue, with model-specific effect sizes |
| Human target engagement | Moderate-High | Peripheral NAD+ and related metabolite shifts are repeatedly demonstrable |
| Clinical efficacy certainty | Low-Moderate | Signals exist, but definitive disease-modifying outcomes remain limited |
| Actionability today | Moderate | Reasonable for biomarker-guided adjunctive use; premature as stand-alone disease-modifying therapy |
Overall interpretation: NAD+ signaling is one of the most coherent metabolism-linked pathways in neurodegeneration, but translation requires biomarker-anchored precision rather than generalized supplementation assumptions.lautrup2019 2019, lautrup2019hou2021 2021, hou2021yoshino2018 2018, NAD+ intermediates: the biology and therapeutic potential of NMN and NRmartens2018 2018, martens2018